1-3 of 3
Elaine M. Hurt
Close
Sort by
Journal Articles

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression

Christina M. Annunziata, Lidia Hernandez, R. Eric Davis, Adriana Zingone, Laurence Lamy, Lloyd T. Lam, Elaine M. Hurt, Arthur L. Shaffer, W. Michael Kuehl, Louis M. Staudt
Journal: Blood
Blood (2011) 117 (8): 2396–2404.
https://doi.org/10.1182/blood-2010-04-278788
Published: 2011
Includes: Supplemental data
Journal Articles

The STATus of miR-21 in apoptosis

Elaine M. Hurt, William L. Farrar
Journal: Blood
Blood (2007) 110 (4): 1086–1087.
https://doi.org/10.1182/blood-2007-05-091413
Published: 2007
Journal Articles

Integrated molecular profiling of SOD2 expression in multiple myeloma

Elaine M. Hurt, Suneetha B. Thomas, Benjamin Peng, William L. Farrar
Journal: Blood
Blood (2006) 109 (9): 3953–3962.
https://doi.org/10.1182/blood-2006-07-035162
Published: 2006
Includes: Supplemental data